In this week’s cancer news there’s Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.
Our scientists are developing a new experimental drug to target how cancer cells repair their DNA, and upset cancer’s balance.
The year is 2016, Breast Cancer Awareness Month is upon us, and right now, 8 in 10 women diagnosed with breast cancer will survive their disease for 10 years or more.
Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey?
Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren’t. We explore why.
Cancer drugs approved, a tiny microscope for spotting cancer cells, engineering molecules so cells can ‘sense’ and why some £5 olive oil isn’t worth it.
Our chief executive, Harpal Kumar, has received a knighthood for services to cancer research
We explore the impact that Tomas Lindahl’s Nobel Prize-winning research into how cells repair their DNA has helped cancer research.
Here are a few highlights from the research projects our Science Committee funded in April.